Articles related to Ophthalmology

The FDA granted 510(k) clearance for a wireless-enabled pressure-modulating goggle system designed to reduce nocturnal intraocular pressure in adults with open-angle glaucoma, with availability expected in Q4 2026.

A retinal specialist reviewing GLP-1 ocular safety evidence at the Retina World Congress concluded that current data do not support withholding therapy based on ocular risk alone, while recommending baseline retinal examination and closer monitoring in patients with preexisting severe diabetic retinopathy.

A retrospective cohort study of 349,168 propensity-matched patients with diabetes found a hazard ratio of 2.22 for nonarteritic anterior ischemic optic neuropathy among semaglutide users compared with non-GLP-1 RA antidiabetic therapy users, with elevated risk emerging at two years and persisting through four years of follow-up.

Researchers at the National University of Singapore developed a spinach-derived nanotechnology delivering plant photosynthetic machinery into corneal cells via eye drops, demonstrating reversal of corneal damage to near-healthy levels within five days in preclinical models of dry eye disease.

A case-control study identified covert mortality nodavirus, previously known only in aquatic animals, in iris tissue of patients with persistent ocular hypertensive viral anterior uveitis, with exposure risk concentrated among those who handle or consume raw aquatic animals daily.

Bausch + Lomb launched PreserVision AREDS3, a reformulation of its established AREDS2 supplement adding a proprietary B-vitamin complex, citing a narrative review of more than 20 human studies linking B-vitamin supplementation to reduced AMD risk.